Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
August 15 2018 - 10:25AM
Edgar (US Regulatory)
|
UNITED STATES
|
|
|
SECURITIES AND EXCHANGE
COMMISSION
|
SEC File No:
000-54563
|
|
Washington, D.C. 20549
|
CUSIP No: 74048 K 10
4
|
FORM 12b-25
NOTIFICATION OF LATE
FILING
(Check
One):
◻ Form
10-K ◻ Form
20-F ◻ Form
11-K ☒ Form
10-Q ◻ Form
10-D ◻ Form
N-SAR ◻ Form
N-CSR
For Period Ended:
June
30
,
2018
◻
|
Transition report on Form 10-K
|
◻
|
Transition report on Form 20-F
|
◻
|
Transition report on Form 11-K
|
◻
|
Transition report on Form 10-Q
|
◻
|
Transition report on Form N-SAR
|
For the Transition Period Ended:
__________________
Nothing in this form shall
be construed to imply that the Commission has verified any
information contained herein.
|
If the notification relates to a portion of the
filing checked above, identify the Item(s) to which the
notification relates: _______________________
PART 1 -- REGISTRANT
INFORMATION
|
|
Premier Biomedical,
Inc.
|
Full Name of Registrant
|
|
Former Name if Applicable
|
|
P.O. Box
25
|
Address of Principal Executive Office
(
Street and
Number)
|
|
Jackson Center, PA
16133
|
City, State and Zip Code
|
PART II -- RULES
12b-25(b) AND (c)
If the subject report could not be filed
without unreasonable effort or expense and the registrant seeks
relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate)
☒
|
|
(a)
|
The reasons described in reasonable detail in
Part III of this form could not be eliminated without unreasonable
effort or expense;
|
|
(b)
|
The subject annual report, semi-annual
report, transition report on Form 10-K, Form 20-F, Form 11-K, Form
N-SAR or Form N-CSR, or a portion thereof, will be filed on or
before the fifteenth calendar day following the prescribed due
date; or the subject quarterly report or transition report on Form
10-Q, or subject distribution report on Form 10-D, or portion
thereof, will be filed on or before the fifth calendar day
following the prescribed due date; and
|
|
(c)
|
The accountant's statement or other exhibit
required by Rule 12b-25(c) has been attached if
applicable.
|
PART III --
NARRATIVE
State below in reasonable detail the reasons
why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the
transition report or portion thereof, could not be filed within the
prescribed time period.
The Form 10-Q could
not be filed within the prescribed time period because we need
additional time to compile and review data and other information
regarding certain material operations of the Company. This data and
information are not currently available and could not be made
available without unreasonable effort and expense. We are actively
working to compile and review this information.
PART IV-- OTHER
INFORMATION
(1) Name and telephone number of person to
contact in regard to this notification
William
Hartman
|
|
814
|
|
786-8849
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
(2) Have all other periodic reports required
under Section 13 or 15(d) of the Securities Exchange Act of 1934 or
Section 30 of the Investment Company Act of 1940 during the
preceding 12 months or for such shorter period that the registrant
was required to file such report(s) been filed? If answer is no,
identify report(s). ☒ Yes ◻
No
(3) Is it anticipated that any significant
change in results of operations from the corresponding period for
the last fiscal year will be reflected by the earnings statements
to be included in the subject report or portion
thereof? ◻ Yes ☒ No
If so, attach an explanation of the
anticipated change, both narratively and quantitatively, and, if
appropriate, state the reasons why a reasonable estimate of the
results cannot be made.
Premier Biomedical, Inc.
|
(Name of Registrant as Specified in
Charter)
|
has caused this notification to be signed on
its behalf by the undersigned hereunto duly
authorized.
Date August 14, 2018
|
By
|
/s/ William A.
Hartman
|
|
|
|
William A. Hartman
|
|
|
|
Chief Executive Officer
|
|
Premier Biomedical (PK) (USOTC:BIEI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Premier Biomedical (PK) (USOTC:BIEI)
Historical Stock Chart
From Apr 2023 to Apr 2024